We are international
Donate
• videos TEXT SIZE   
webcasts from medical meetings    back

Mohamad A. Hussein, MD
Leader, Multiple Myeloma Clinical Research
H. Lee Moffitt Cancer & Research Institute
Tampa, Florida
Cost Effectiveness of Pegylated liposomal doxorubicin DOXIL®/CAELYX®)vs. doxorubicin in the VAd regimen (DVd) to treat multiple myeloma
06.14.04
Pegylated liposomal doxorubicin (DOXIL®/CAELYX®)was used in place of doxorubicin in the VAd regimen (DVd) to treat multiple myeloma. This study evaluates the cost effectiveness (CE) of these 2 regimens.


 related articles